Signia Capital Management’s Biostage, Inc. Common Stock BSTG Stock Holding History

Signia Capital Management’s Portfolio BSTG Stock Details BSTG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-24,666	Closed	-$80K	–	65
2015 Q1	$80K	Sell	24,666 -42,339	-63%	-$144K	0.21%	58
2014 Q4	$213K	Hold	67,005	–	–	0.11%	64
2014 Q3	$543K	Hold	67,005	–	–	0.29%	60
2014 Q2	$700K	Buy	67,005 +43,796	+189%	+$373K	0.31%	58
2014 Q1	$211K	Hold	23,209	–	–	0.08%	75
2013 Q4	$110K	Buy	+23,209	New	+$109K	0.04%	77

Other funds holding BSTG

State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

WIC

Woodmont Investment Counsel Nashville, Tennessee $1.83B AUM 25.91% 1-Year Est. Return

Signia Capital Management's BSTG Position: Q2 2015 in Review

Signia Capital Management sold out of Biostage, Inc. Common Stock (BSTG) in Q2 2015, closing a stake of 24,666 shares — an estimated $80K sold.

Signia Capital Management first reported a position in BSTG in Q4 2013 and held it in 6 quarters. The position peaked at $700K in Q2 2014. 32 funds tracked by Wall St. Rank hold BSTG as of Q2 2015.

Signia Capital Management reported no remaining Biostage, Inc. Common Stock position as of Q2 2015 after selling out during the quarter.
Signia Capital Management sold 24,666 Biostage, Inc. Common Stock shares in Q2 2015, an estimated $80K.
Signia Capital Management first reported a position in Biostage, Inc. Common Stock in Q4 2013 and held it in 6 quarters.
Signia Capital Management's Biostage, Inc. Common Stock position peaked at $700K in Q2 2014.
32 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q2 2015.

Based on Signia Capital Management's 13F filing for Q2 2015, filed 12 Aug 2015.